PerryBoryeeShiehMDPhD
Neurology • Los Angeles, CANeuromuscular Medicine, Neurophysiology
Professor of Neurology and Pediatrics, UCLA School of Medicine
Dr. Shieh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 UCLA Medical Plaza
Suite B200
Los Angeles, CA 90095Phone+1 310-825-3264Fax+1 310-825-3264- Is this information wrong?
Summary
- Dr. Perry Shieh is a neurologist at the University of California Los Angeles (UCLA). He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 17 years. He specializes in neuromuscular medicine and neurophysiology and is experienced in neuromuscular medicine and clinical neurophysiology. He has more than 70 publications and over 500 citings.
Education & Training
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 2004 - 2005
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2001 - 2004
Yale-New Haven Medical CenterInternship, Internal Medicine, 2000 - 2001
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2024- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies Start of enrollment: 2010 Feb 01
- A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy Start of enrollment: 2012 May 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry.Laurent Servais, John W Day, Darryl C De Vivo, Janbernd Kirschner, Eugenio Mercuri, Francesco Muntoni, Crystal M Proud, Perry B Shieh, Eduardo F Tizzano, Susana Quijan...> ;Journal of Neuromuscular Diseases. 2024 Jan 1
- Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ...Lawlor, M., Schoser, B., Margeta, M., Sewry, C., Jones, K., Shieh, P., Kuntz, N., Smith, B., Dowling, J., Müller-Felber, W., Bönnemann, C., Seferian, A., Blaschek, A.,...> ;Ebiomedicine. 2024 Jan 1
- 6 citationsSafety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.Perry B Shieh, Nancy L Kuntz, James J Dowling, Wolfgang Müller-Felber, Carsten G Bönnemann, Andreea M Seferian, Laurent Servais, Barbara K Smith, Francesco Muntoni, As...> ;The Lancet. Neurology. 2023 Dec 1
- Join now to see all
Press Mentions
Muscular Dystrophy Gene Therapy Nears Approval, but Safety Concerns LingerMay 23rd, 2023
Astellas to Acquire Audentes for $3B, Seeing Gene Therapy as “Key Driver”December 3rd, 2019
CBS 2 Exclusive: Man’s Incurable, Deadly Disease Could Be Treated — if He Had $400,000 A YearMay 20th, 2017
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
